Clinical trial · Observational

The Relationship Between the Tumor Markers and Interstitial Lung Disease

NCT04597814CI-TRIAL-00047884completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
No Intervention	Other	—	UNRESOLVED

Design

Arms and outcomes

Arms (2)

label
interstitial lung disease patients
description
interstitial lung disease patients who need lung transplantation
interventionNames
1. Other: No Intervention
label
non- interstitial lung disease patients
description
non- interstitial lung disease patients who need thoracic surgery to remove pneumatocele
interventionNames
1. Other: No Intervention

Primary outcomes (9)

measure
serum levels of carcinoembryonic antigen (CEA)
timeFrame
6months
description
serum levels of carcinoembryonic antigen (CEA)

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 20 Years
Maximum age: 80 Years

Show eligibility criteria text

Inclusion Criteria

1.Interstitial lung disease patients for lung transplantation

\-

Exclusion Criteria:

1. tumor
2. Interstitial lung disease patients could not be performed by lung transplantation

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Jan 1, 2019
Primary completion: Oct 15, 2020
Completion: Oct 15, 2020
First posted: Oct 22, 2020
Last update posted: Oct 23, 2020
Enrollment: 13 (actual)
Lead sponsor: The First Affiliated Hospital of Guangzhou Medical University OTHER
Keywords: carcinoembryonic antigen, carbohydrate antigen 19-9, carbohydrate antigen 125

Data updated 22 days agoSource updated Oct 23, 2020source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
China	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.